PTK6 and breast carcinoma: In addition, it resulted in a marked inhibition of the phosphorylation of Brk in a cell-free Z′-LYTETM kinase assay (Life Technologies, Grand Island, NY, USA) and Western blot analysis in the human breast cancer cells MDA-MB-231 [13].